India · National
PopVax CEO on personalised cancer vaccines: ‘Experimental option, not established cure’
The Hyderabad-based startup’s new RNA Foundry will design custom tumour-targeting vaccines, but the tech remains strictly experimental. Founder and CEO Soham Sankaran explains how the process works and talks about the future of oncology care
Verified Timeline
No verified timeline updates.
What is your view on “PopVax CEO on personalised cancer vaccines: ‘Experimental option, not established cure’”?
This is self-selected reader participation, not representative scientific polling.

